🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementFAERS pharmacovigilance data for semaglutide — July 2024 Page 3

FAERS pharmacovigilance data for semaglutide — July 2024

MASHdoc_SA Fri, May 16, 2025 at 3:40 AM 11 replies 1,426 viewsPage 3 of 3
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
May 16, 2025 at 5:28 PM#11
sarah_TO said:
Start from the measurement rather than the conclusion.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Last edited: May 16, 2025 at 6:28 PM
11 9SkepticalSean, Dr.CardioMD, EndoResFellow and 8 others
Reply Quote Save Share Report
B12Beth
Member
289
890
Oct 2024
Maryland
May 17, 2025 at 2:54 AM#12
lori_vegas said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

Saving this. It is the first explanation that did not require me to already understand it. Sending this to two other people who asked me the same thing last week.

Last edited: May 17, 2025 at 5:54 AM
12 10carl_compliance, DanielChem_CHI, marco_milano and 9 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
May 17, 2025 at 12:20 PM#13
sarah_TO said:
Start from the measurement rather than the conclusion.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

13 11maya_sedona, stefan_berlin, Dr.EM_Chicago and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 17, 2025 at 9:45 PM#14

Adding the numbers, since they settle part of this. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

14 12ricardo_MIA, BrianDallas92, labquiet_amy and 11 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 18, 2025 at 7:10 AM#15

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. No action needed from anybody.

15 13PurityPaulOR, MaxMetOK, MounjBrad and 12 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register